Delee (2022)
About this raise
Delee, with a valuation of $22 million, is raising funds on Republic. The company has created a device, CytoCatch, for the early detection of circulating tumor cells in the bloodstream. The device also assists in the personalization and optimization of the treatment of patients and monitors the effectiveness of treatments. Thus, CytoCatch helps to increase the chances of curing cancer and survival. Delee already has a fully functional technology that is being tested for prostate cancer and breast cancer and will start its research use-only sales by Q4 of 2022. Liza Velarde, Juan Felipe Yee, and Alejandro Abarca founded Delee in November 2016. The current crowdfunding campaign has a minimum target of $25,000 and a maximum target of $4,000,000. The campaign proceeds will be used for the completion of clinical studies, the establishment of multiple collaborations, and commercial launch of the technology.
Investment Overview
Invested $204,059 :
Deal Terms
Company & Team
Company
- Year Founded
- 2016
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2B
- Margin
- Medium
- Capital Intensity
- High
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Company Funding & Growth
Funding history
- Total Prior Capital Raised
- $1,590,498
- VC Backed?
- Yes
Offering Name | Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
---|---|---|---|---|---|---|---|
Delee | 12/16/2022 | Republic | $22,000,000 | $204,059 | SAFE | Funded | RegCF |
Delee | 04/06/2022 | StartEngine | $22,040,057 | $347,498 | Equity - Preferred | Funded | RegCF |
Delee | 04/24/2020 | Republic | $10,000,000 | $1,070,000 | SAFE | Funded | RegCF |
Growth Charts
Revenue History
Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.
Valuation History
Price per Share History
Note: Share prices shown in earlier rounds may not be indicative of any stock splits.